Xin Lang Cai Jing·2025-11-06 03:33Core Viewpoint - Spring Medical experienced a decline of 1.78% in stock price on November 5, with a trading volume of 107 million yuan, indicating a potential market reaction to recent financial data and trading activities [1] Financing Summary - On November 5, Spring Medical had a financing buy-in amount of 10.17 million yuan and a financing repayment of 9.76 million yuan, resulting in a net financing buy of 413,500 yuan [1] - As of November 5, the total financing and securities lending balance for Spring Medical was 44.53 million yuan, which accounts for 0.56% of its market capitalization, indicating a high level of financing activity compared to the past year [1] - The financing balance is above the 90th percentile of the past year, suggesting strong investor interest [1] Securities Lending Summary - On November 5, there were no shares repaid or sold in securities lending, resulting in a sell amount of 0 yuan [1] - The securities lending balance was also 0, which is above the 80th percentile of the past year, indicating a lack of short-selling activity [1] Company Overview - Beijing Spring Medical Co., Ltd. specializes in the research, production, and sales of implantable orthopedic medical devices, with a focus on joint prosthetics and spinal implants [2] - The company was established on February 12, 1998, and went public on December 30, 2021, with its products exported to various regions including Asia, South America, Africa, Oceania, and Europe [2] - For the period from January to September 2025, Spring Medical reported a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit of 192 million yuan, reflecting a significant increase of 213.21% [2] Dividend Summary - Since its A-share listing, Spring Medical has distributed a total of 359 million yuan in dividends, with 309 million yuan paid out over the last three years [3] Institutional Holdings Summary - As of September 30, 2025, the top ten circulating shareholders of Spring Medical included new entrants such as Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed Fund A, holding 2.96 million shares and 2.83 million shares respectively [3] - The holdings of Ping An Low Carbon Economy Mixed Fund A decreased by 1.67 million shares, while Southern Medical Health Flexible Allocation Mixed Fund A exited the top ten circulating shareholders [3]